Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow

Breast Cancer Research and Treatment

Volumn 117, Issue 1, 2009, Pages 61-68

  Lucci, Anthony ^a   Krishnamurthy, Savitri ^a   Singh, Balraj ^a   Bedrosian, Isabelle ^a   Meric Bernstam, Funda ^a   Reuben, James ^a   Broglio, Kristine ^a   Mosalpuria, Kailash ^a   Lodhi, Ashutosh ^a   Vincent, Laura ^a   Cristofanilli, Massimo ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Bone marrow micrometastasis; Breast cancer; COX2; Disseminated tumor cells; Minimal residual disease

Indexed keywords

CYCLOOXYGENASE 2; CYTOKERATIN;

ADULT; AGED; ARTICLE; BONE MARROW METASTASIS; BREAST CANCER; CANCER STAGING; CONTROLLED STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROMETASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW NEOPLASMS; BREAST NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL;

EID: 69049112248     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0135-x     Document Type: Article

References (40)

1. S Braun FD Vogl B Naume W Janni MP Osborne et al. 2005 A pooled analysis of bone marrow micrometastasis in breast cancer N Engl J Med 353 793 802 10.1056/NEJMoa050434
2. MJ Slade A Singh BM Smith G Tripuraneni E Hall et al. 2005 Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years Int J Cancer 114 94 100 10.1002/ijc.20655
3. G Wiedswang E Borgen C Schirmer R Karesen G Kvalheim et al. 2006 Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer Int J Cancer 118 2013 2019 10.1002/ijc.21576
4. U Wolfle V Muller K Pantel 2006 Disseminated tumor cells in breast cancer: detection, characterization and clinical relevance Future Oncol 2 553 561 10.2217/14796694.2.4.553
5. M Lacroix 2006 Significance, detection and markers of disseminated breast cancer cells Endocr Relat Cancer 13 1033 1067 10.1677/ERC-06-0001
6. IJ Fidler SJ Kim RR Langley 2007 The role of the organ microenvironment in the biology and therapy of cancer metastasis J Cell Biochem 101 927 936 10.1002/jcb.21148
7. M Cristofanilli KR Broglio V Guarneri S Jackson HA Fritsche et al. 2007 Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden Clin Breast Cancer 7 471 479
8. B Singh A Lucci 2002 Role of cyclooxygenase-2 in breast cancer J Surg Res 108 173 179 10.1006/jsre.2002.6532
9. LR Howe AJ Dannenberg 2003 COX-2 inhibitors for the prevention of breast cancer J Mammary Gland Biol Neoplasia 8 31 43 10.1023/A:1025731204719
10. D Wang RN Dubois 2004 Cyclooxygenase-2: a potential target in breast cancer Semin Oncol 31 64 73 10.1053/j.seminoncol.2004.01.008
11. B Singh JA Berry A Shoher GD Ayers C Wei et al. 2007 COX-2 involvement in breast cancer metastasis to bone Oncogene 26 3789 3796 10.1038/sj.onc.1210154
12. B Singh JA Berry A Shoher V Ramakrishnan A Lucci 2005 COX-2 overexpression increases motility and invasion of breast cancer cells Int J Oncol 26 1393 1399
13. B Singh JA Berry LE Vincent A Lucci 2006 Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer J Surg Res 134 44 51 10.1016/j.jss.2006.03.018
14. B Singh JA Berry A Shoher A Lucci 2006 COX-2 induces IL-11 production in human breast cancer cells J Surg Res 131 267 275 10.1016/j.jss.2005.11.582
15. O Kudo A Sabokbar A Pocock I Itonaga Y Fujikawa et al. 2003 Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism Bone 32 1 7 10.1016/S8756-3282(02)00915-8
16. H Morgan A Tumber PA Hill 2004 Breast cancer cells induce osteoclast formation by stimulating host IL-11 production and downregulating granulocyte/macrophage colony-stimulating factor Int J Cancer 109 653 660 10.1002/ijc.20056
17. S Hanavadi TA Martin G Watkins RE Mansel WG Jiang 2006 Expression of interleukin 11 and its receptor and their prognostic value in human breast cancer Ann Surg Oncol 13 802 808 10.1245/ASO.2006.05.028
18. MS Bendre AG Margulies B Walser NS Akel S Bhattacharrya et al. 2005 Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappa B ligand pathway Cancer Res 65 11001 11009 10.1158/0008-5472.CAN-05-2630
19. IH Benoy R Salgado P Van Dam K Geboers E Van Marck et al. 2004 Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival Clin Cancer Res 10 7157 7162 10.1158/1078-0432.CCR-04-0812
20. G Roche-Nagle EM Connolly M Eng DJ Bouchier-Hayes JH Harmey 2004 Antimetastatic activity of a cyclooxygenase-2 inhibitor Br J Cancer 91 359 365
21. AH Macchetti HR Marana JS Silva JM de Andrade A Ribeiro-Silva et al. 2006 Tumor-infiltrating CD4+ T lymphocytes in early breast cancer reflect lymph node involvement Clinics 61 203 208
22. EY Lin JF Li L Gnatovskiy Y Deng L Zhu et al. 2006 Macrophages regulate the angiogenic switch in a mouse model of breast cancer Cancer Res 66 11238 11246 10.1158/0008-5472.CAN-06-1278
23. WH Faour Y He QW He M de Ladurantaye M Quintero et al. 2001 Prostaglandin E(2) regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts J Biol Chem 276 31720 31731 10.1074/jbc.M104036200
24. K Subbaramaiah L Norton W Gerald AJ Dannenberg 2002 Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3 J Biol Chem 277 18649 18657 10.1074/jbc.M111415200
25. SC Wang HC Lien W Xia IF Chen HW Lo et al. 2004 Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2 Cancer Cell 6 251 261 10.1016/j.ccr.2004.07.012
26. KJ Schmitz R Callies J Wohlschlaeger R Kimmig F Otterbach et al. 2006 Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neu signalling pathways J Clin Pathol 59 685 691 10.1136/jcp. 2005.030650
27. G Wiedswang AB Naess B Naume R Karesen 2001 Micrometastasis to axillary lymph nodes and bone marrow in breast cancer patients Breast 10 237 242 10.1054/brst.2000.0245
28. A Ristimaki A Sivula J Lundin M Lundin T Salminen et al. 2002 Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer Cancer Res 62 632 635
29. GS Ranger V Thomas A Jewell K Mokbel 2004 Elevated cyclooxygenase-2 expression correlates with distant metastases in breast cancer Anticancer Res 24 2349 2351
30. MP Zerkowski RL Camp BA Burtness DL Rimm GG Chung 2007 Quantitative analysis of breast cancer tissue microarrays shows high cox-2 expression is associated with poor outcome Cancer Invest 25 19 26 10.1080/07357900601128825
31. B Singh L Vincent JA Berry AS Multani A Lucci 2007 Cyclooxygenase-2 expression induces genomic instability in MCF10A breast epithelial cells J Surg Res 140 220 226 10.1016/j.jss.2007.01.039
32. B Singh KR Cook L Vincent CS Hall JA Berry AS Multani et al. 2008 Cyclooxygenase-2 induces genomic instability, BLC2 expression, doxorubicin resistance, and altered cancer-inhibiting cell phenotype in MCF7 breast cancer cells J Surg Res 147 240 246 10.1016/j.jss.2008.02.026
33. AJ Minn GP Gupta PM Siegel PD Bos W Shu DD Giri et al. 2005 Genes that mediate breast cancer metastasis to lung Nature 436 518 524 10.1038/nature03799
34. M Balic H Lin L Young D Hawes A Giuliano et al. 2006 Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype Clin Cancer Res 12 5615 5621 10.1158/1078-0432.CCR-06-0169
35. 2 protects mouse embryonic stem cells from apoptosis Stem Cells 25 1096 1103 10.1634/stemcells.2006-0505
36. 2 and peroxisome proliferator-activated receptor omega promotes mouse embryonic stem cells proliferation Stem Cells 26 745 755 10.1634/stemcells.2007-0786
37. V Bozionellou D Mavroudis M Perraki S Papadopoulos S Apostolaki et al. 2004 Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer Clin Cancer Res 10 8185 8194 10.1158/1078-0432.CCR-03-0094
38. SE Kimmel JA Berlin M Reilly J Jaskowiak L Kishel et al. 2005 Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction Ann Intern Med 142 157 164
39. P McGettigan D Henry 2006 Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2 JAMA 296 1633 1644 10.1001/jama.296.13.jrv60011
40. JM Wu MJ Fackler MK Halushka DW Molavi ME Taylor et al. 2008 Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases Clin Cancer Res 14 1938 1946 10.1158/1078-0432.CCR-07-4082